Clinical Trial Update: LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LiftActiv B3 in Post Inflammatory Hyperpigmentation has been terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne
• Post-inflammatory Hyperpigmentation

Drugs mentioned

• LiftActiv B3

Snippet

Sponsor: University of Miami | Conditions: Acne, Post Inflammatory Hyperpigmentation | Phase 2 | Status: TERMINATED | Results posted: 2024-04-03